BSE filing, NSE: DDIL. Summary written from the filing by ALFA Finder's alert engine.
Deep Health AI India Ltd: key numbers
- Share price
- ₹1.60
- Market cap
- ₹23.06 Cr
- Revenue (annual)
- ₹4.25 Cr
- Net profit (annual)
- ₹1.13 Cr
- P/E (TTM)
- -21.4×Sector 49.0×
- Promoter holding
- 0.03%+0.00% QoQ
- FII holding
- 0.35%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Deep Health AI India Ltd
All →Deep Health AI India Other Announcement
Deep Health AI India Ltd filed its quarterly shareholding pattern for the quarter ended September 30, 2026, as per regulatory requirements.
Deep Health AI India Acquisition Worth ₹10.35 Cr
Deep Health AI India Limited acquired debt and underlying security from Kshitij Polyline Limited for ₹10.35 Crore. The assignment secures rights in Sparion Infrastructure Private Limited.
- Value
- ₹10.35 Cr
Deep Health AI India Management Change
Deep Health AI India Limited appointed Virendra Choubisa as Non-Executive Director and M/s Vimal C Surana as statutory auditor, replacing outgoing auditor M/s VRSK & Co. LLP.
Deep Health AI India Annual General Meeting
Deep Health AI India Limited successfully concluded its 32nd Annual General Meeting on September 30, 2026, where all proposed resolutions were passed by the members.
Deep Health AI India Management Change
Deep Health AI India Limited has announced the resignation of Mr. Rajesh Nandkishore Pherwani as a Non-Executive Independent Director, effective September 11, 2026.
Deep Health AI India Other Announcement
Deep Health AI India sent a Reg 36(1)(b) letter to shareholders with unregistered emails, providing the Annual Report FY25-26 weblink and AGM e-voting details. No financial or business substance is disclosed.
Other board meeting outcome announcements
All →R R Kabel Board Meeting Outcome
RR Kabel's board approved amendments to its UPSI fair disclosure code on 28 October 2026. The amended code is enclosed and posted on the company website.
M K Exim (India) Board Meeting Outcome
M.K. Exim (India) approved shifting its registered office within Jaipur to Plot J-1247, Sitapura. The board meeting was held on October 28, 2026.
United Spirits Board Meeting Outcome
United Spirits' board approved amendments to its insider trading code on 28 October 2026, effective 29 October 2026. The revised code is available on the company website.
SBI Funds Management Board Meeting Outcome
SBI Funds Management extended internal auditor Chhajed & Doshi's term to March 31, 2030. This routine decision was taken at the October 28, 2026 board meeting.
- Execution
- April 1, 2028 to March 31, 2030
Paras Healthcare Board Meeting Outcome
Paras Healthcare filed its board-approved UPSI fair disclosure code under Regulation 8(2). This routine governance policy update reports no business event.
Gateway Distriparks Board Meeting Outcome
Gateway Distriparks' board approved a revised Code of Practices for Fair Disclosure of UPSI under PIT Regulation 8(2). This is a routine governance policy update with no business event.